Growth Metrics

Bruker (BRKR) Accumulated Expenses (2016 - 2025)

Bruker filings provide 16 years of Accumulated Expenses readings, the most recent being $179.7 million for Q4 2025.

  • On a quarterly basis, Accumulated Expenses rose 2395.83% to $179.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $179.7 million, a 2395.83% increase, with the full-year FY2025 number at $179.7 million, up 2395.83% from a year prior.
  • Accumulated Expenses hit $179.7 million in Q4 2025 for Bruker, up from $7.2 million in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $179.7 million in Q4 2025 to a low of $600000.0 in Q4 2022.
  • Median Accumulated Expenses over the past 5 years was $8.4 million (2023), compared with a mean of $65.6 million.
  • Biggest five-year swings in Accumulated Expenses: plummeted 99.55% in 2022 and later skyrocketed 2395.83% in 2025.
  • Bruker's Accumulated Expenses stood at $132.0 million in 2021, then plummeted by 99.55% to $600000.0 in 2022, then skyrocketed by 1300.0% to $8.4 million in 2023, then dropped by 14.29% to $7.2 million in 2024, then skyrocketed by 2395.83% to $179.7 million in 2025.
  • The last three reported values for Accumulated Expenses were $179.7 million (Q4 2025), $7.2 million (Q4 2024), and $8.4 million (Q4 2023) per Business Quant data.